Sanofi

Company Snapshot

Founded: 1994
Entity Type: Public
Employees: 82,878
Region: U.S.
Revenue: $44,458.3 Millions
Revenue Year: 2024
Segment: Biopharma segment
Headquarter: Paris, France
Key Geographics: U.S., Europe, Rest of the World

Company Overview

Sanofi is a global life sciences company committed to discovering, developing, and distributing safe and effective medicines. The company manufactures and markets pharmaceuticals, vaccines, and animal health products. The company has a wide global presence and dominates the U.S. and European markets. Sanofi operates primarily in two business segments: biopharma and consumer healthcare. For all geographic territories, the Biopharma operating segment comprises commercial operations and research, development, and production activities associated with Specialty Care, General Medicines, and Vaccine franchises. More than 180 countries can purchase Sanofi products, and the company operates in nearly 70 countries.

Sanofi In Reports

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

BCC Research expert says the Therapies for Rheumatoid Arthritis market report analyzes the market trends of therapies for rheumatoid arthritis with data from 2024, estimates from 2025, projections of CAGR through 2030. ...

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

BCC Research Market Analyst says global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025.

Global Markets for Infectious Disease Treatments

BCC Research Market Analyst says global market for infectious disease treatments is expected to grow from $72.5 billion in 2025 and is projected to reach $101 billion by the end of 2030.

Company's Business Segments

  • Biopharma segment : Biopharma segment comprises Specialty Care, General Medicines and Vaccines businesses for example Dupixent, Aubagio, Myozyme, Fabrazyme, Cerezyme, Eloctate, Alprolix, Nexviazyme, Jevtana, Sarclisa, Kevzara, Cerdelga, Aldurazyme,Cablivi and others
  • Consumer Healthcare segment : The Consumer Healthcare operating segment comprises commercial operations relating to Consumer Healthcare products, Research, development and production activities and global support functions dedicated to the segment. for example AllergyCough, Cold and Flu, Pain, Care, Digestive, Wellness, Physical and Mental Wellness, Personal Care and Others

Applications/End User Industries

  • Diabetes Products Companies
  • Cardiovascular Diseases
  • Neurological Disorders
  • Pharmacists
  • Medical Professionals
  • Clinics
  • Public Health Organizations
  • Healthcare Policymakers
  • Vitamins Manufacturing
  • Supplements Manufacturing
  • Skincare Manufacturing
  • Clinical Trials
  • Scientific Research
AI: Your Say